Taysha Gene Therapies, Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-0
Book Value Per Share
$1
Free Cash Flow Per Share
$-0
Cash Per Share
$1
Revenue Per Share
$0
OCF Per Share
$-0
Return on Equity
-68.5%
Return on Assets
-43.3%
Return on Invested Capital
-42.3%
Debt to Equity
0.20
Current Ratio
12.23
Quick Ratio
12.23
Asset Turnover
0.04
R&D / Revenue
884.1%
SBC / Revenue
136.1%
Capex / Revenue
7.6%
Working Capital
$298M
Net Current Asset Value
$228M
Invested Capital
$297M
OCF / Net Income
0.85
FCF / Net Income
0.86
Accruals Ratio (Sloan)
-4.6%
Net Debt
$-270M
Net Debt / EBITDA
2.47
Interest Coverage
-1753.94
Cash Coverage
-1477.62
Capex Coverage
-126.14
Tangible Common Equity
$247M
TCE / Total Assets
71.9%
NOPAT
$-87M
Cash ROIC
-45.5%
WC / Revenue
3050.2%
Capex / D&A
0.64
Reinvestment Rate
0.4%
Asset Growth vs Revenue Growth
96.8%
Book Value 5Y CAGR
-0.3%
Stock Price (FY-end)
$6
Market Cap
$1.76B
P/S Ratio
179.93
P/B Ratio
7.12
P/TB Ratio
7.12
Enterprise Value
$1.49B
EV / Sales
152.33
FCF Yield
-5.3%
Shareholder Yield
-0.8%
R&D Yield
4.9%
Capex Yield
0.0%
Shares Variation (YoY)
27.8%
Beta (5Y)
1.90
Cost of Equity
14.0%
Cost of Debt (after tax)
0.1%
WACC
13.3%
ROIC - WACC Spread
-75.9%
52W High
$6
52W Low
$1
Trailing Return 1Y
214.3%
Trailing Return 5Y
-80.4%
F-Score (Piotroski)
4.00
Z-Score (Altman)
8.05
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.